CELCUITY INC's ticker is CELC and the CUSIP is 15102K100. A total of 43 filers reported holding CELCUITY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79 | -14.1% | 8,590 | +2.3% | 0.00% | – |
| Q2 2023 | $92 | -90.8% | 8,400 | +10532.9% | 0.00% | – |
| Q2 2022 | $1,000 | -98.4% | 79 | -98.9% | 0.00% | – |
| Q1 2022 | $64,000 | -29.7% | 6,879 | 0.0% | 0.00% | – |
| Q4 2021 | $91,000 | -26.6% | 6,879 | 0.0% | 0.00% | – |
| Q3 2021 | $124,000 | -23.9% | 6,879 | +1.2% | 0.00% | – |
| Q2 2021 | $163,000 | +288.1% | 6,800 | +4.6% | 0.00% | – |
| Q1 2020 | $42,000 | -39.1% | 6,500 | 0.0% | 0.00% | – |
| Q4 2019 | $69,000 | -37.3% | 6,500 | 0.0% | 0.00% | – |
| Q3 2019 | $110,000 | -32.5% | 6,500 | 0.0% | 0.00% | – |
| Q2 2019 | $163,000 | +14.8% | 6,500 | 0.0% | 0.00% | – |
| Q1 2019 | $142,000 | -9.0% | 6,500 | 0.0% | 0.00% | – |
| Q4 2018 | $156,000 | -16.6% | 6,500 | 0.0% | 0.00% | – |
| Q3 2018 | $187,000 | +16.1% | 6,500 | 0.0% | 0.00% | – |
| Q2 2018 | $161,000 | +906.2% | 6,500 | +550.0% | 0.00% | – |
| Q1 2018 | $16,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 1,250,001 | $31,791,305 | 2.46% |
| VR Adviser, LLC | 2,105,386 | $19,243,228 | 2.03% |
| COMMODORE CAPITAL LP | 1,694,141 | $15,484,449 | 1.81% |
| Soleus Capital Management, L.P. | 2,056,484 | $18,796,264 | 1.73% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 63,209 | $577,730 | 0.82% |
| RA Capital Management | 1,400,001 | $12,796,009 | 0.25% |
| GAGNON SECURITIES LLC | 54,010 | $493,651 | 0.12% |
| PFM Health Sciences, LP | 210,551 | $1,924,436 | 0.09% |
| J. Goldman & Co LP | 148,500 | $1,357,290 | 0.05% |
| Murphy Pohlad Asset Management LLC | 11,200 | $102,368 | 0.04% |